PLYMOUTH MEETING, Pa. (AP) _ Inovio Pharmaceuticals Inc. (INO) on Thursday reported a loss of $29.4 million in its second quarter.
The Plymouth Meeting, Pennsylvania-based company said it had a loss of 30 cents per share.
The results did not meet Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 28 cents per share.
The drugmaker posted revenue of $135,700 in the period. Its adjusted revenue was $136,000, which also missed Street forecasts. Three analysts surveyed by Zacks expected $4.7 million.
In the final minutes of trading on Thursday, the company's shares hit $2.54. A year ago, they were trading at $4.48.